CLINICAL_TRIALS
trial_result
· 2020-05-07
Clinical Trial Update: Glargine U300 Hospital Trial [Phase 4]
Summary
Phase 4 clinical trial update for Glargine U300 in hospitalized patients with Type 2 diabetes; trial completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2020-05-07